Chemomab Therapeutics CMMB Cash Flow Statement (2011-2026)

NASDAQ CMMB
$1.19 +0.01 (+0.85%)
As of: Oct 21, 2026 · 1:28 PM EDT
Reported Financials

Chemomab Therapeutics Quarterly Cash Flow Statement

Periods 41 quarters
Latest Jun 2026

Chemomab Therapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 41 quarters of results from Jun 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2011 Sep2011 Dec2011 Jun2012 Sep2012 Dec2012 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-2.97M-5.04M-5.10M-6.19M-8.08M-8.27M-8.75M-7.97M-4.08M-3.42M-3.87M-3.63M3.48M-24.93M-3.32M-2.06M1.74M-16.12M-1.77M-2.17M
Depreciation and DepletionDep. & Depletion
0.01M0.01M0.01M0.01M0.02M0.01M0.02M0.02M0.02M0.02M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
Depreciation & Amortization (CF)Dep. & Amort.
0.01M0.01M0.01M0.01M0.02M0.01M0.02M0.02M0.02M0.02M
Share-based CompensationStock Comp.
0.44M1.01M0.87M0.76M0.84M0.74M0.48M0.64M0.13M0.24M
Gains from Sales and DivestituresGains Divest
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
Change in Working Capital
Change in ReceivablesChange Receivables
Change in Account PayablesChange Payables
0.01M0.85M0.15M-0.05M-0.19M0.44M0.53M0.13M-1.62M-0.22M
Change in Accured ExpensesChange Accured Exp.
-0.27M-0.02M0.69M0.46M0.87M0.80M-0.21M-0.66M0.50M-0.37M
Change in TaxesChange Taxes
Change in Other Operating AssetsOther Assets Change
-0.38M-0.09M0.36M1.12M-0.88M-0.54M-0.81M0.00M1.79M-1.88M
Change in Other Operating LiabilitiesOther Liabilities Change
0.00M0.01M-0.03M0.00M0.00M0.00M0.00M0.02M
Other Working Capital ChangesOther WC Changes
0.38M0.09M-0.35M-1.15M0.88M0.54M0.81M-0.01M-1.79M1.90M
Other Operating ActivitiesOther Ops.
Cash from OperationsCash from Ops.
-2.58M-2.89M-3.71M-5.70M-5.26M-5.70M-7.19M-7.49M-5.22M-3.72M
Investing Activities
Capital ExpendituresCapex
0.13M0.01M0.01M0.04M0.00M0.00M0.00M-0.01M0.01M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-0.13M-0.01M-0.01M-0.04M0.00M0.00M0.00M0.01M-0.01M
Change in Acquisitions & DivestmentsChange Acquisitions
6.12M3.99M
Cash from Investing ActivitiesCash from Investing
-5.00M-19.58M2.38M1.73M6.07M9.35M14.43M-4.27M3.99M1.72M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
-0.01M15.10M0.02M0.04M0.35M1.37M2.13M
Net Shares Issued and RepurchasedNet Shares Issued
-0.01M15.10M0.02M0.04M0.35M1.37M2.13M
Net Equity Issued and RepurchasedNet Equity Issued
-0.01M15.10M0.02M0.04M0.35M1.37M2.13M
Other financing activitiesOther financing
-2.43M-1.22M
Cash from Financing ActivitiesCash from Financing
-0.07M-0.08M0.02M0.04M-0.87M1.37M0.00M2.13M
Additional items
Exchange Rate EffectFX Effect
Change in Cash
-7.65M-22.56M-1.33M-3.95M0.86M2.78M7.25M-10.39M-1.23M0.14M
Ending Cash Balance
37.80M15.24M13.91M9.96M10.82M13.60M20.84M10.46M9.23M9.37M5.11M6.15M5.60M7.56M6.00M
Free Cash FlowFCF
-2.58M-3.03M-3.73M-5.71M-5.30M-5.70M-7.19M-7.49M-5.22M-3.72M
Net Cash FlowNCF
-7.65M-22.56M-1.33M-3.95M0.86M2.78M7.25M-10.39M-1.23M0.14M
Interest Paid
Income Taxes PaidTaxes Paid

Chemomab Therapeutics Cash Flow Statement API

Pull Chemomab Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CMMB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY